Your browser doesn't support javascript.
loading
The efficacy and safety of paclitaxel plus bevacizumab therapy in breast cancer patients with visceral crisis.
Funasaka, Chikako; Naito, Yoichi; Kusuhara, Shota; Nakao, Takehiro; Fukasawa, Yoko; Mamishin, Kanako; Komuro, Ayumi; Okunaka, Mashiro; Kondoh, Chihiro; Harano, Kenichi; Kogawa, Takahiro; Matsubara, Nobuaki; Hosono, Ako; Kawasaki, Toshikatsu; Mukohara, Toru.
Afiliação
  • Funasaka C; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
  • Naito Y; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japa
  • Kusuhara S; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
  • Nakao T; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Fukasawa Y; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
  • Mamishin K; Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Komuro A; Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Okunaka M; Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kondoh C; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
  • Harano K; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kogawa T; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan.
  • Matsubara N; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan.
  • Hosono A; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan; Department of General Internal Medicine, National Cancer Center Hospital East, Kashiwa, Japan.
  • Kawasaki T; Department of Pharmacy, National Cancer Center Hospital East, Kashiwa, Japan.
  • Mukohara T; Department of Medical Onology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa 277-8577, Japan. Electronic address: tmukohar@east.ncc.go.jp.
Breast ; 58: 50-56, 2021 Aug.
Article em En | MEDLINE | ID: mdl-33901922
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Paclitaxel Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Paclitaxel Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article